ODTX · Odyssey Therapeutics, Inc. · Exempt Offerings
$19.23
+0.35 (+1.85%)
At close · Nov 6
Return incl. dividend (before tax)
Market Cap
$897.43M
Shares
48.07M
Volume · Nov 6
577.26K
Avg daily vol (3M)
285.94K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-12-04 | New | Biotechnology | $214,025,200 | $214,025,200 | 06b |
| 2024-08-14 | Amendment | Biotechnology | $121,080,000 | $117,210,000 | 06b |
| 2023-12-15 | New | Biotechnology | $106,000,000 | $97,130,000 | 06b |
| 2022-10-27 | New | Biotechnology | $174,909,939 | $168,009,933 | 06b |
| 2021-10-14 | New | Biotechnology | Indefinite | $91,629,837 | 06b |
Showing 1–5 of 5 filings
Key facts
CIK
1882782
CUSIP
67613T104
13F (30d)
11 filings
11 filers
Visit website
Investor relations